33
Participants
Start Date
August 14, 2023
Primary Completion Date
December 23, 2023
Study Completion Date
December 23, 2023
instillation of NOV03
This trial consists of 2 office visits over a period of approximately 2 weeks. At Visit 2, a designated clinical staff member or the investigator will instill 1 drop of NOV03 into each eye.
Site 101, Miami
Bausch & Lomb Incorporated
INDUSTRY